NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Suzhou Forlong Biotechnology Co., Ltd.

Suzhou Forlong Biotechnology Co., Ltd.

Private
SuzhouHealthcare & Life Scienceshttp://forlongbiotech.com.cn/

Last Round

Early Funding

May 19, 2026

Total Funding Raised

$15M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Suzhou Forlong Biotechnology Co., Ltd. is a biotechnology company that develops next-generation cytokine therapeutics for cancer treatment.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Application

Keywords

cytokine therapyimmuno-oncologycancer immunotherapyengineered cytokinesfusion proteindrug discovery platformclinical-stage biotechIL-15 superagonistlong half-life biologicsAI drug discoveryFc engineeringbiotech licensingsolid tumor therapyNK cell activationIL-18 therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Suzhou Forlong Biotechnology Co., Ltd. Comparables

Compare Suzhou Forlong Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.

Suzhou Forlong Biotechnology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Simcha Therapeutics
85%
Sotio
78%
Synthekine
77%

Suzhou Forlong Biotechnology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingMay 19, 2026
Series AFeb 7, 2023
AngelNov 1, 2021

Suzhou Forlong Biotechnology Co., Ltd. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 19, 2026

    $18M raised with participation from Changshu Guofa Venture Capital.

  • Feb 7, 2023

    $15M round led by Puhua Capital.

Suzhou Forlong Biotechnology Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Suzhou Forlong Biotechnology Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Suzhou Forlong Biotechnology Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSuzhou
Year Founded2019
Last FundingMay 19, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.